Details for New Drug Application (NDA): 213229
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 213229
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Hikma |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 213229
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 213229
Suppliers and Packaging for NDA: 213229
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 213229 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9338 | 0143-9338-25 | 25 VIAL in 1 CARTON (0143-9338-25) / 10 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Jun 12, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription